[Coagulation Factor IX (Recombinant)]

Baxalta US, Inc.

RIXUBIS (Coagulation Factor IX [Recombinant]) is an antihemophilic factor indicated in adults and children with hemophilia B for:

• Control and prevention of bleeding episodes, perioperative management, and routine prophylaxis. (1)

RIXUBIS is not indicated for induction of immune tolerance in patients with Hemophilia B.

Store at refrigerated temperature [2°C to 8°C (36°C to 46°F)] or room temperature [not to exceed 30°C (86°F)] for up to 36 months. Do not freeze. Do not use beyond the expiration date printed on the carton or vial.